For someone with Type 1 diabetes, an insulin pump isn’t a convenience, it’s a lifeline, delivering precise, continuous doses of insulin around the clock. When that medical device fails, the consequences can be immediate and severe.
The Medtronic MiniMed 600-series recall centers on a small plastic component called a retainer ring, which locks the insulin reservoir securely in place.
When it cracks or goes missing, the reservoir can come loose, and the pump can deliver far too much insulin or far too little, with no warning until symptoms appear.
Prior results do not guarantee a similar outcome.
What the Retainer Ring Defect Actually Does
The retainer ring holds the insulin reservoir, the cartridge that contains the insulin, securely locked inside the pump. When that ring breaks or goes missing, often after the pump is dropped or bumped, the reservoir can lose its proper alignment.
The FDA described the resulting risk plainly, a loose reservoir can lead to unintended over-delivery or under-delivery of insulin. Too much insulin can trigger severe hypoglycemia.
Too little can lead to hyperglycemia and, eventually, diabetic ketoacidosis, a life-threatening condition where the body starts breaking down fat for fuel and producing dangerous, acidic ketones as a byproduct.
Both directions are genuinely dangerous. What makes a device failure like this particularly frightening is that it can happen silently, while someone sleeps, drives, or goes about an ordinary day, with no obvious warning until the physical symptoms are already underway.
What FDA’s Recall Actually Covered
Medtronic initiated the recall of MiniMed 600-series pumps with the clear retainer ring design on November 21, 2019, covering the MiniMed 630G (distributed in the U.S. from September 2016 to October 2019) and MiniMed 670G (distributed from June 2017 to August 2019).
FDA classified this as a Class I recall in February 2020, its most serious category, reserved for situations where there’s a reasonable probability that using the device will cause serious harm or death. In October 2021, Medtronic expanded its response, offering to replace every qualifying 600-series pump with the clear ring design for an updated black retainer ring, including pumps with no visible damage.
At the time of the original recall, Medtronic had reported 26,421 complaints of retainer ring malfunctions, 2,175 injuries, and one death connected to the malfunction pattern.
One more thing worth being clear about not every recent MiniMed recall involves this retainer ring issue. In October 2024, FDA announced a separate Class I recall for certain MiniMed 600- and 700-series pumps over shorter-than-expected battery life after a dropped or impacted device, a different mechanism entirely.
A 2025 action addressed a further separate concern involving air pressure changes during air travel, classified as Class II. If your pump issue involves one of these other problems rather than a damaged retainer ring, the relevant facts and timeline are different from what’s discussed here.
What New York Product Liability Law Requires
A claim like this generally proceeds under one or more of three theories.
A design defect claim argues the retainer ring itself was unreasonably prone to failure under normal use, evaluated under New York’s risk-utility framework, did Medtronic use a reasonably safe design, or were the risks of this particular design great enough that a reasonable manufacturer would have used an alternative?
A manufacturing defect claim focuses more narrowly on whether your specific pump departed from Medtronic’s own intended specifications.
A failure to warn claim asks whether patients and healthcare providers were adequately warned about the risk, and how quickly Medtronic acted once it knew.
To succeed, you generally need to show the device was defective when it left Medtronic’s control, that the defect was a direct cause of your injury, and that you were using the device in a reasonably foreseeable way.
The recall itself is genuinely useful evidence here, since it shows Medtronic acknowledged a safety problem serious enough to warrant company and FDA action, which can support what the company knew and when.
What Evidence Actually Matters
If your pump malfunctioned, the physical device is central evidence, so don’t discard it, and don’t return it to Medtronic without preserving a copy of its data first.
Beyond the pump itself, preserve the model and serial number, any recall letters or replacement communications you received, pump alarm and error message history, continuous glucose monitor data, and complete medical records from the emergency, including lab results showing glucose, ketone, and electrolyte levels.
Document what you remember: when symptoms started, what the pump displayed, and what your glucose readings looked like in the hours beforehand. This kind of detail helps experts reconstruct exactly what happened and connect the device failure to your specific injury.
How Long You Have to File
This is an important distinction from other toxic exposure or latent-injury cases: a device malfunction like this is generally treated as an acute injury, not a latent chemical exposure, so New York’s discovery rule for latent toxic exposure isn’t the framework that applies here.
For most product liability personal injury claims, New York generally allows three years from the date of injury, and a wrongful death claim generally must be filed within two years of the date of death.
Because the exact deadline can shift depending on the specific legal theory and facts involved, it’s worth having your timeline reviewed rather than assuming a single rule applies.
Summing It Up
A defective medical device case depends on connecting a mechanical failure to a medical emergency, which takes both engineering and medical expertise working together.
If you or a loved one has been harmed by a malfunctioning MiniMed insulin pump, Porter Law Group can help you understand your options.
Call 833-PORTER9, email info@porterlawteam.com, or visit porterprotects.com/contact.
Frequently Asked Questions
My pump was replaced under the 2021 program, but I was harmed before that. Does the replacement affect my claim?
Not necessarily. If your injury occurred before your pump was replaced, the replacement itself doesn’t erase what already happened. What matters for a claim is the condition of the device at the time of the malfunction and injury, not whether the model was later updated. It’s worth having your specific timeline and medical records reviewed regardless of your pump’s current status.
Does the fact that Medtronic didn’t confirm the reported deaths and injuries were caused by the retainer ring hurt my case?
Not automatically. That statement reflects Medtronic’s own broad review across all reported events, not a specific evaluation of your case. Your claim still depends on your own medical records, pump data, and expert review connecting your specific device malfunction to your specific injury, independent of how Medtronic characterized the aggregate numbers.
I have a different MiniMed recall, not the retainer ring one. Does this apply to me?
Not directly. The retainer ring recall discussed here is a distinct issue from later, separate recalls, including a 2024 battery-life recall and a 2025 recall related to air pressure changes during air travel. If your situation involves one of those other issues, the relevant facts, mechanism, and timeline are different, so it’s worth having your specific model and recall history reviewed on its own.
Is there a class action or settlement I can just join?
Not currently in a way that resolves individual claims automatically. The retainer ring litigation is proceeding as a federal multidistrict litigation, and the first trial concluded with a plaintiffs’ verdict that Medtronic is now challenging. There’s no finalized, global settlement structure at this point, which means pursuing your own claim, whether individually or as part of the coordinated litigation, still requires its own evidence and timeline.
What should I do if I’m still using an affected pump?
Confirm your specific model and whether it has the clear retainer ring design, and don’t assume a replaced or black-ring pump is automatically risk-free without verifying its status directly with Medtronic or your care team. Keep backup insulin and injection supplies available, and follow your diabetes care team’s individualized plan for a suspected pump failure. If you experience DKA symptoms or severe hypoglycemia, seek emergency medical care immediately rather than waiting to see if it resolves.
This article is for informational and educational purposes only. It is not a substitute for medical advice from a qualified healthcare provider or legal advice based on your specific circumstances.
If you or a loved one has been harmed by a malfunctioning MiniMed insulin pump, Porter Law Group can help you understand your options. Call 833-PORTER9, email info@porterlawteam.com, or visit porterprotects.com/contact.
